65
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Extracellular vesicles (EVs) are natural nanoparticles that mediate intercellular transfer of RNA and proteins and are of great medical interest; serving as novel biomarkers and potential therapeutic agents. However, there is little consensus on the most appropriate method to isolate high-yield and high-purity EVs from various biological fluids. Here, we describe a systematic comparison between two protocols for EV purification: ultrafiltration with subsequent liquid chromatography (UF-LC) and differential ultracentrifugation (UC). A significantly higher EV yield resulted from UF-LC as compared to UC, without affecting vesicle protein composition. Importantly, we provide novel evidence that, in contrast to UC-purified EVs, the biophysical properties of UF-LC-purified EVs are preserved, leading to a different in vivo biodistribution, with less accumulation in lungs. Finally, we show that UF-LC is scalable and adaptable for EV isolation from complex media types such as stem cell media, which is of huge significance for future clinical applications involving EVs.

          Related collections

          Author and article information

          Journal
          Nanomedicine
          Nanomedicine : nanotechnology, biology, and medicine
          1549-9642
          1549-9634
          May 2015
          : 11
          : 4
          Affiliations
          [1 ] Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
          [2 ] Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
          [3 ] Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom; Institute of Technology, University of Tartu, Tartu, Estonia.
          [4 ] Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
          [5 ] Novartis Institutes for Biomedical Research, Basel, Switzerland.
          [6 ] Department of Neurochemistry, Stockholm University, Stockholm, Sweden.
          [7 ] Molecular Engineering Laboratory, Proteos, Agency for Science, Technology and Research (A*STAR), Singapore.
          [8 ] Department of Medicine Solna, Translational Immunology Unit, Karolinska Institutet and University Hospital, Stockholm, Sweden.
          [9 ] Umeå Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
          [10 ] Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
          [11 ] Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom. Electronic address: matthew.wood@dpag.ox.ac.uk.
          [12 ] Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom. Electronic address: Samir.El-Andaloussi@ki.se.
          Article
          S1549-9634(15)00027-1
          10.1016/j.nano.2015.01.003
          25659648
          f8df8c5c-8fe3-4d9a-a6ad-d455698e2c96
          Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Biophysical properties,extracellular vesicles,size-exclusion liquid chromatography,ultracentrifugation,ultrafiltration

          Comments

          Comment on this article